|
1
|
Vine KL, Matesic L, Locke JM, Ranson M and
Skropeta D: Cytotoxic and anticancer activities of isatin and its
derivatives: A comprehensive review from 2000-2008. Anticancer
Agents Med Chem. 9:397–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blažević T, Heiss EH, Atanasov AG, Breuss
JM, Dirsch VM and Uhrin P: Indirubin and indirubin derivatives for
counteracting proliferative diseases. Evid Based Complement
Alternat Med. 2015:6540982015. View Article : Google Scholar
|
|
3
|
Medvedev A, Buneeva O and Glover V:
Biological targets for isatin and its analogues: Implications for
therapy. Biologics. 1:151–162. 2007.PubMed/NCBI
|
|
4
|
Premanathan M, Radhakrishnan S,
Kulangiappar K, Singaravelu G, Thirumalaiarasu V, Sivakumar T and
Kathiresan K: Antioxidant & anticancer activities of isatin
(1H-indole-2,3-dione), isolated from the flowers of Couroupita
guianensis Aubl. Indian J Med Res. 136:822–826. 2012.
|
|
5
|
Stafman LL and Beierle EA: Cell
proliferation in neuroblastoma. Cancers (Basel). 8:132016.
View Article : Google Scholar
|
|
6
|
Buhagiar A and Ayers D: Chemoresistance,
cancer stem cells, and miRNA influences: The case for
neuroblastoma. Anal Cell Pathol (Amst). 2015:1506342015.
|
|
7
|
Strother DR, London WB, Schmidt ML,
Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S,
Reynolds CP, et al: Outcome after surgery alone or with restricted
use of chemotherapy for patients with low-risk neuroblastoma:
Results of Children's Oncology Group study P9641. J Clin Oncol.
30:1842–1848. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kreissman SG, Seeger RC, Matthay KK,
London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL,
Diller L, et al: Purged versus non-purged peripheral blood
stem-cell transplantation for high-risk neuroblastoma (COG A3973):
A randomised phase 3 trial. Lancet Oncol. 14:999–1008. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu AL, Gilman AL, Ozkaynak MF, London WB,
Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay
KK, et al: Anti-GD2 antibody with GM-CSF, inter-leukin-2, and
isotretinoin for neuroblastoma. N Engl J Med. 363:1324–1334. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pinto NR, Applebaum MA, Volchenboum SL,
Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F,
Schleiermacher G, Park JR, et al: Advances in risk classification
and treatment strategies for neuroblastoma. J Clin Oncol.
33:3008–3017. 2016. View Article : Google Scholar
|
|
11
|
Hara J: Development of treatment
strategies for advanced neuro-blastoma. Int J Clin Oncol.
17:196–203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mazalovska M and Kouokam JC: Plant-derived
lectins as potential cancer therapeutics and diagnostic tools.
Biomed Res Int. 2020:16313942020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han K, Zhou Y, Liu F, Guo Q, Wang P, Yang
Y, Song B, Liu W, Yao Q, Teng Y and Yu P: Design, synthesis and in
vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin
derivatives as anticancer agents. Bioorg Med Chem Lett. 24:591–594.
2014. View Article : Google Scholar
|
|
14
|
Pakravan P, Kashanian S, Khodaei MM and
Harding FJ: Biochemical and pharmacological characterization of
isatin and its derivatives: From structure to activity. Pharmacol
Rep. 65:313–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Watkins P, Clow A, Glover V, Halket J,
Przyborowska A and Sandler M: Isatin, regional distribution in rat
brain and tissues. Neurochem Int. 17:321–323. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou P and Koh HL: Determination of
indican, isatin, indirubin and indigotin in Isatis indigotica by
liquid chromatography/electrospray ionization tandem mass
spectrometry. Rapid Commun Mass Spectrom. 21:1239–1246. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schulte JH, Lim S, Schramm A, Friedrichs
N, Koster J, Versteeg R, Ora I, Pajtler K, Klein-Hitpass L,
Kuhfittig-Kulle S, et al: Lysine-specific demethylase 1 is strongly
expressed in poorly differentiated neuroblastoma: Implications for
therapy. Cancer Res. 69:2065–2071. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sakane C, Okitsu T, Wada A, Sagami H and
Shidoji Y: Inhibition of lysine-specific demethylase 1 by the
acyclic diterpenoid geranylgeranoic acid and its derivatives.
Biochem Biophys Res Commun. 444:24–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rotili D and Mai A: Targeting histone
demethylases A new avenue for the fight against cancer. Genes
Cancer. 2:663–679. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu
W, Liang J, Sun L, Yang X, Shi L, et al: LSD1 is a subunit of the
NuRD complex and targets the metastasis programs in breast cancer.
Cell. 138:660–672. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xue M, Liang H, Ji X, Liu Y and Sun T:
Fucoidan prevent murine autoimmune diabetes via suppression
TLR4-signaling pathways, regulation DC/Treg induced immune
tolerance and improving gut microecology. Nutr Metab (Lond).
16:872019. View Article : Google Scholar
|
|
23
|
Soleimani A, Khazaei M, Ferns GA, Ryzhikov
M, Avan A and Hassanian SM: Role of TGF-β signaling regulatory
microRNAs in the pathogenesis of colorectal cancer. J Cell Physiol.
Jan 26–2019.Epub ahead of print. View Article : Google Scholar
|
|
24
|
Rössler J, Breit S, Havers W and
Schweigerer L: Vascular endothelial growth factor expression in
human neuroblastoma: Up-regulation by hypoxia. Int J Cancer.
81:113–117. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tamamura R, Nagatsuka H, Siar CH, Katase
N, Naito I, Sado Y and Nagai N: Comparative analysis of basal
lamina type IV collagen α chains, matrix metalloproteinases-2 and
-9 expressions in oral dysplasia and invasive carcinoma. Acta
Histochem. 115:113–119. 2013. View Article : Google Scholar
|
|
26
|
Lanza C, Galeazzi V, Carboni N, De
Berardinis A, De Marino L, Barile A and Giovagnoni A: Neuroblastoma
image-defined risk factors in adrenal neuroblastoma: Role of
radiologist. Gland Surg. 8(Suppl 3): S168–S177. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Orr KE and McHugh K: The new international
neuroblastoma response criteria. Pediatr Radiol. 49:1433–1440.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Belczacka I, Latosinska A, Siwy J, Metzger
J, Merseburger AS, Mischak H, Vlahou A, Frantzi M and Jankowski V:
Urinary CE-MS peptide marker pattern for detection of solid tumors.
Sci Rep. 8:52272018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zage PE: Novel therapies for relapsed and
refractory neuroblastoma. Children (Basel). 5:1482018.
|
|
30
|
Morandi F, Frassoni F, Ponzoni M and
Brignole C: Novel immunotherapeutic approaches for neuroblastoma
and malignant melanoma. J Immunol Res. 2018:80973982018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gencer N, Sonmez F, Demir D, Arslan O and
Kucukislamoglu M: Synthesis, structure-activity relationships and
biological activity of new isatin derivatives as tyrosinase
inhibitors. Curr Top Med Chem. 14:1450–1462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma Z, Hou L, Jiang Y, Chen Y and Song J:
The endogenous oxindole isatin induces apoptosis of MCF7 breast
cancer cells through a mitochondrial pathway. Oncol Rep.
32:2111–2117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin H, Ju C, Zhang J, Song J, Ge Y and
Wang Y: Antitumor effects of Isatin on human neuroblastoma cell
line (SH-SY5Y) and the related mechanism. Eur J Pharmacol.
589:27–31. 2008. View Article : Google Scholar
|
|
34
|
Song J, Hou L, Ju C, Zhang J, Ge Y and Yue
W: Isatin inhibits proliferation and induces apoptosis of SH-SY5Y
neuroblastoma cells in vitro and in vivo. Eur J Pharmacol.
702:235–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu P, Hou L, Ju C, Zhang Z, Sun W, Zhang
L, Song J, Lv Y, Liu L, Chen Z and Wang Y: Isatin inhibits the
proliferation and invasion of SH-SY5Y neuroblastoma cells. Mol Med
Rep. 13:2757–2762. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Sun W, Cao Y, Hou L and Wang X:
Isatin inhibits the invasion of human neuroblastoma SH-SY5Y cells,
based on microarray analysis. Mol Med Rep. 20:1700–1706.
2019.PubMed/NCBI
|
|
37
|
Schildhaus HU, Riegel R, Hartmann W,
Steiner S, Wardelmann E, Merkelbach-Bruse S, Tanaka S, Sonobe H,
Schüle R, Buettner R and Kirfel J: Lysine-specific demethylase 1 is
highly expressed in solitary fibrous tumors, synovial sarcomas,
rhabdomyosarcomas, desmoplastic small round cell tumors, and
malignant peripheral nerve sheath tumors. Hum Pathol. 42:1667–1675.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Khandanpour C and Möröy T: Growth factor
independence 1 (Gfi1) as a regulator of p53 activity and a new
therapeutical target for ALL. Oncotarget. 4:374–375. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bandopadhyay M, Sarkar N, Datta S, Das D,
Pal A, Panigrahi R, Banerjee A, Panda CK, Das C, Chakrabarti S and
Chakravarty R: Hepatitis B virus X protein mediated suppression of
miRNA-122 expression enhances hepatoblastoma cell proliferation
through cyclin G1-p53 axis. Infect Agent Cancer. 11:402016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun W, Zhang L, Hou L, Ju C, Zhao S and
Wei Y: Isatin inhibits SH-SY5Y neuroblastoma cell invasion and
metastasis through MAO/HIF-1α/CXCR4 signaling. Anti Cancer Drugs.
28:645–653. 2017. View Article : Google Scholar
|
|
41
|
Itatani Y, Kawada K and Sakai Y:
Transforming growth factor-β signaling pathway in colorectal cancer
and its tumor microenvi-ronment. Int J Mol Sci. 20:58222019.
View Article : Google Scholar
|
|
42
|
Lee HJ: The role of tripartite motif
family proteins in TGF-β signaling pathway and cancer. J Cancer
Prev. 23:162–169. 2018. View Article : Google Scholar
|
|
43
|
Xie F, Ling L, van Dam H, Zhou F and Zhang
L: TGF-β signaling in cancer metastasis. Acta Biochim Biophys Sin
(Shanghai). 50:121–132. 2018. View Article : Google Scholar
|
